DN

Dhananjayan Nair Vanajayan

Active Director Partner DIN 11774085
DIN 11774085 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhananjayan Nair Vanajayan

Data last updated:

Dhananjayan Nair Vanajayan is a Partner at Marko Pharma Distributors Llp (since 2026) and Designated Partner at Ammavan Pharma Distributors Llp (since 2026).

DIN 11774085
Primary Designation Partner
First Appointment 17 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner16 Jul 20262026Active
Designated Partner17 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Ammavan Pharma Distributors Llp
Marko Pharma Distributors Llp
Premium access

Shareholding and investment profile for Dhananjayan Nair Vanajayan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhananjayan Nair Vanajayan

Dhananjayan Nair Vanajayan currently holds 2 directorships: Marko Pharma Distributors Llp (Partner, since 16 Jul 2026); Ammavan Pharma Distributors Llp (Designated Partner, since 17 Jun 2026).

Dhananjayan Nair Vanajayan was first appointed on 17 Jun 2026 as Designated Partner at Ammavan Pharma Distributors Llp.

The current boards of Dhananjayan Nair Vanajayan's companies include Manoharan Thulaseedharan Nair (Marko Pharma Distributors Llp), Mohankumar Gopakumari Didtu (Marko Pharma Distributors Llp), Vijayakumar Thankappan (Marko Pharma Distributors Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available